Regulatory T cells, maternal-foetal immune tolerance and recurrent miscarriage: new therapeutic challenging opportunities

Med Clin (Barc). 2015 Mar 15;144(6):265-8. doi: 10.1016/j.medcli.2014.01.033. Epub 2014 Mar 22.

Abstract

Because maternal alloreactive lymphocytes are not depleted during pregnancy, local and/or systemic mechanisms have to play a key role in altering the maternal immune response. Peripheral T regulatory cells (pTregs) at the maternal-foetal interface are necessary in situ to prevent early abortion, but only those pTregs that have been previously exposed to paternal alloantigens. It has been showed that pregnancy selectively stimulates the accumulation of maternal Foxp3(+)CD4(+)CD25(+) (Foxp3Tregs) cells with foetal specificity. Interestingly, after delivery, foetal-specific pTregs persist at elevated levels, maintain tolerance to pre-existing foetal antigen, and rapidly re-accumulate during subsequent pregnancy. pTreg up-regulation could be hypothesized as a possible future therapeutic strategy in humans.

Keywords: Abortos recurrentes; Citocinas; Cytokines; Células NK/KIR; Fracaso implantatorio; Implantation failure; Linfocitos T reguladores; Maternal–foetal tolerance; Miscarriages; NK cells/KIR; Regulatory-T lymphocytes; Tolerancia maternofetal; Tratamiento; Treatment.

Publication types

  • Review

MeSH terms

  • Abortion, Habitual / immunology*
  • Abortion, Habitual / therapy
  • Biomarkers / metabolism
  • Female
  • Fetus / immunology
  • Forkhead Transcription Factors / metabolism
  • Humans
  • Immune Tolerance*
  • Maternal-Fetal Exchange / immunology*
  • Pregnancy
  • T-Lymphocytes, Regulatory / metabolism*

Substances

  • Biomarkers
  • FOXP3 protein, human
  • Forkhead Transcription Factors